Hamad A.; Sahli Z.; El Sabban M.; Mouteirik M.; Nasr R.
(NEW YORK410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA, 2013)
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder. Current targeted therapies designed to inhibit the tyrosine kinase activity of the BCR-ABL oncoprotein have made a significant breakthrough in the ...